Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence
- PMID: 15767367
- PMCID: PMC2213104
- DOI: 10.1084/jem.20041442
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence
Abstract
Viral immune evasion strategies target key aspects of the host antiviral response. Recently, it has been recognized that Toll-like receptors (TLRs) have a role in innate defense against viruses. Here, we define the function of the vaccinia virus (VV) protein A46R and show it inhibits intracellular signalling by a range of TLRs. TLR signalling is triggered by homotypic interactions between the Toll-like-interleukin-1 resistance (TIR) domains of the receptors and adaptor molecules. A46R contains a TIR domain and is the only viral TIR domain-containing protein identified to date. We demonstrate that A46R targets the host TIR adaptors myeloid differentiation factor 88 (MyD88), MyD88 adaptor-like, TIR domain-containing adaptor inducing IFN-beta (TRIF), and the TRIF-related adaptor molecule and thereby interferes with downstream activation of mitogen-activated protein kinases and nuclear factor kappaB. TRIF mediates activation of interferon (IFN) regulatory factor 3 (IRF3) and induction of IFN-beta by TLR3 and TLR4 and suppresses VV replication in macrophages. Here, A46R disrupted TRIF-induced IRF3 activation and induction of the TRIF-dependent gene regulated on activation, normal T cell expressed and secreted. Furthermore, we show that A46R is functionally distinct from another described VV TLR inhibitor, A52R. Importantly, VV lacking the A46R gene was attenuated in a murine intranasal model, demonstrating the importance of A46R for VV virulence.
Figures






Similar articles
-
Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8. doi: 10.1073/pnas.0308496101. Epub 2004 Feb 24. Proc Natl Acad Sci U S A. 2004. PMID: 14982987 Free PMC article.
-
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.Science. 2003 Aug 1;301(5633):640-3. doi: 10.1126/science.1087262. Epub 2003 Jul 10. Science. 2003. PMID: 12855817
-
Modulation of Toll-interleukin 1 receptor mediated signaling.J Mol Med (Berl). 2005 Apr;83(4):258-66. doi: 10.1007/s00109-004-0622-4. Epub 2005 Jan 21. J Mol Med (Berl). 2005. PMID: 15662540 Review.
-
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.Nat Immunol. 2003 Feb;4(2):161-7. doi: 10.1038/ni886. Epub 2003 Jan 21. Nat Immunol. 2003. PMID: 12539043
-
TIR domain-containing adaptors define the specificity of TLR signaling.Mol Immunol. 2004 Feb;40(12):861-8. doi: 10.1016/j.molimm.2003.10.006. Mol Immunol. 2004. PMID: 14698224 Review.
Cited by
-
Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses.Viruses. 2016 May 23;8(5):139. doi: 10.3390/v8050139. Viruses. 2016. PMID: 27223301 Free PMC article.
-
Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.J Virol. 2012 Dec;86(23):12605-15. doi: 10.1128/JVI.00246-12. Epub 2012 Sep 12. J Virol. 2012. PMID: 22973033 Free PMC article.
-
Severe sepsis and Toll-like receptors.Semin Immunopathol. 2008 Feb;30(1):29-40. doi: 10.1007/s00281-007-0101-4. Epub 2007 Dec 11. Semin Immunopathol. 2008. PMID: 18071706 Review.
-
Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies.J Virol. 2014 Mar;88(6):3067-76. doi: 10.1128/JVI.03510-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335286 Free PMC article.
-
A novel TLR3 inhibitor encoded by African swine fever virus (ASFV).Arch Virol. 2011 Apr;156(4):597-609. doi: 10.1007/s00705-010-0894-7. Epub 2011 Jan 4. Arch Virol. 2011. PMID: 21203785 Free PMC article.
References
-
- Janeway, C.A. Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197–216. - PubMed
-
- Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335–376. - PubMed
-
- Dunne, A., and L.A.J. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE. 2003:re3. - PubMed
-
- Zhang, D., G. Zhang, M.S. Hayden, M.B. Greenblatt, C. Bussey, R.A. Flavell, and S. Ghosh. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 303:1522–1526. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources